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The 4070A amphotropic murine leukemia virus (A-MuLV) has been variably reported to harbor neurovirulence determi-
nants within its env gene. In this report we reexamined this issue by applying two approaches previously demonstrated to
amplify murine leukemia virus neurovirulence. The first approach involved introducing the 4070A env gene into the
background of Friend virus clone FB29 to enhance peripheral virus replication kinetics and central nervous system entry. The
resulting chimeric virus, FrAmE, exhibited widespread vascular infection throughout the central nervous system (CNS);
however, parenchymal infection was quite limited. Neither clinical neurological signs nor spongiform neurological changes
accompanied FrAmE CNS infection. To overcome this CNS entry limitation, 4070A and FrAmE were delivered directly into
the CNS via transplantation of infected C17.2 neural stem cells (NSCs). Significantly, NSC dissemination of either 4070A or
FrAmE resulted in widespread, high-level amphotropic virus expression within the CNS parenchyma, including the infection
of microglia, the critical target required for inducing neurodegeneration. Despite the extensive CNS infection, no associated
clinical neurological signs or acute neuropathological changes were observed. Interestingly, we observed the frequent
appearance of circulating polytropic (MCF) virus in the serum of amphotropic virus-infected animals. However, neither
peripheral inoculation of an amphotropic/MCF virus mixture nor transplantation of NSCs expressing both amphotropic and
MCF viruses induced acute clinical neurological signs or spongiform neuropathology. Thus, the results generated in this
study suggest that the 4070A env gene is not inherently neurovirulent. However, the frequent appearance of endogenous
MCF viruses suggests the possibility that the interactions of amphotropic viruses with endogenous retroviral elements could
contribute to the development of retrovirus-induced neurodegenerative disease. © 2002 Elsevier Science (USA)INTRODUCTION
The ability of murine retroviruses to induce neurolog-
ical disease in mice appears to be critically dependent
on three major factors. These include virus entry into the
brain during the perinatal period, the infection of micro-
glia, and the expression of a neurovirulent viral env gene
coincident with the expression of other retroviral struc-
tural elements (reviewed in Lynch and Portis, 2000; Portis
and Lynch, 1998). Virus entry during the perinatal period
is important due to a brain endothelium-associated entry
restriction which arises after the first postnatal week
(Czub et al., 1991, 1992; Gardner et al., 1976). For a virus
to circumvent the endothelial restriction, it must be inoc-
ulated into mice at very high doses (Brooks et al., 1979),
be inoculated into mice at prenatal times (Lynch and
Portis, 1993; Sharpe et al., 1987), or possess rapid neo-
natal peripheral replication kinetics (Czub et al., 1991,
1992; Portis et al., 1990). Importantly, direct inoculation of
virus into the central nervous system (CNS) does not
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262overcome this restriction; however, it can be overcome
by CNS transplantation of virus expressing neural stem
cells (NSCs) or microglia (Lynch et al., 1995, 1996, 1999).
Once virus is disseminated within the parenchyma, mi-
croglia infection occurs, followed by region-specific de-
generation of neuronal elements (Czub et al., 1994; Lynch
et al., 1995, 1996; Robertson et al., 1997). It is important to
emphasize that the neurons which degenerate in this
disease are not infected by murine leukemia viruses
(MuLVs), and any proliferating neurons which do become
infected are not adversely affected (Baszler and Zachary,
1991; Kay et al., 1991; Lynch et al., 1991). Thus, microglial
infection indirectly mediates neuropathological changes,
although how microglial function is altered by neuroviru-
lent virus infection is not yet known.
Genetic mapping analysis has demonstrated that the
primary MuLV neurovirulence determinants lie within the
env gene (reviewed in Jolicoeur et al., 1992; Portis and
Lynch, 1998; Wong and Yuen, 1992). For the prototypic
neurovirulent ecotropic virus CasBrE, this conclusion
was based on the creation of chimeric viruses made
between CasBrE and the experimentally nonneuropatho-Key Words: amphotropic; murine leukemia virus; retrovi
eration; envelope; microglia.
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genic amphotropic virus 4070A (DesGroseillers et al.,
1984). However, a more recent report reexaminingonrus; ne
whether the 4070A env might itself harbor neuroviru-
lence determinants showed that a Moloney MuLV-based
amphotropic virus (MoAmphoV) could induce progres-
sive spongiform neurodegeneration, albeit with a pro-
tracted latency and a limited incidence (Munk et al.,
1997). It was further shown that coinoculation of helper
virus along with MoAmphoV could accelerate neurode-
generation. These findings are of considerable interest
given that amphotropic viruses enter cells via the evolu-
tionarily conserved sodium-dependent phosphate trans-
porter Pit-2, whereas the neurovirulent ecotropic viruses
use the murine cationic amino acid transporter-1
(mCAT-1) for entry. The idea that divergent env genes
could mediate essentially identical neurodegenerative
diseases raises the possibility that Env determinants
outside of the receptor binding domains may be respon-
sible for the induction of spongiform neuropathology.
To evaluate how the amphotropic and ecotropic vi-
ruses could induce strikingly similar neurodegenerative
diseases, we set out to establish herein a rapid and
reliable system for assaying the neuropathogenic poten-
tial of the 4070A amphotropic virus in the absence of
helper virus. To accomplish this goal we employed two
different strategies to amplify the predicted neuropatho-
genic properties of the 4070A env. The first strategy
involved enhancing in vivo virus replication kinetics by
generating a chimeric virus containing the 4070A env
gene inserted into the background of a rapidly replicat-
ing Friend MuLV. The second strategy involved direct
delivery of infectious virus to the brain via transplanted
NSCs. Previously, these strategies have been shown to
dramatically exacerbate the neurological disease asso-
ciated with a marginally neurovirulent CasBrE virus,
clone 15-1 (Lynch et al., 1996; Portis et al., 1990) and have
revealed neuropathogenic properties of an otherwise
nonneurovirulent polytropic virus (Portis et al., 1995;
Poulsen et al., 1999). Interestingly, the results of the
experiments presented here indicate that the 4070A env
does not appear to harbor neurovirulence determinants
per se. Rather, the results suggest that in order to cause
neurodegeneration the amphotropic virus may need to
interact with other retroviral structural elements of exog-
enous or endogenous origin.
RESULTS
Intraperitoneal infection of neonatal IRW mice with
4070A or FrAmE
It has been previously demonstrated that the neuro-
pathogenic potential of both ecotropic and polytropic
viruses could be dramatically enhanced by introducing
the env genes from these viruses into the background of
the Friend virus clone FB29 (Portis et al., 1990, 1995). We
therefore generated a similar FB29 chimeric virus using
the 4070A env, called FrAmE, as outlined in Fig. 1 and
under Materials and Methods. The resulting provirus
structure is depicted along with the other proviral clones
employed in this study. Transfection of the unpermuted
FrAmE proviral DNA into NIH 3T3 cells resulted in the
production of virus with a titer of 2.0  106 focus-forming
units (FFU)/ml of virus supernatant. This virus titer was
essentially the same as that obtained for the wild-type
virus 4070A (1.1  106 FFU/ml). These virus stocks were
inoculated intraperitoneally (ip) into neonatal (P0) inbred
Rocky Mountain White (IRW) mice, which were followed
daily for signs of clinical neurological disease. As sum-
FIG. 1. Amphotropic proviral structures and their derivation. The unpermuted Friend/amphotropic chimeric proviral clone, pFrAmE, was assembled
by inserting the SphI to BsmI fragment (dark gray) of pAMS (Miller and Buttimore, 1986) into the Friend virus chimera pFB29-57E in the pSP72 plasmid.
The unfilled regions of pFB29-57E represent sequences from Friend clone FB29, and the cross-hatched regions represent nucleotide sequences
derived from clone 57 (Sitbon et al., 1986). Ten base pairs of the Fr57 env were retained in the FrAmE chimera which were identical to those in FB29.
The C-terminal sequences from Friend env had no effect on virus production or antibody reactivity. The 4070A virus was derived from permuted
proviral clone p4070A in the pBR322 plasmid (Miller et al., 1985). Virus titers derived from these proviruses are indicated in Table 1.
2634070A RETROVIRUS INTERACTIONS IN THE CNS
marized in Table 1, all the infected mice demonstrated a
circulating viremia at the time they were killed; however,
no clinical signs of disease were noted over the 4-week
time period during which they were evaluated (Table 1).
Immunohistochemical assessment of the 4070A virus-
infected animals at 4 weeks postinoculation indicated
that virus infection of the CNS was typically quite limited,
focal in nature, and primarily associated with vascular
elements (cf., Fig. 2A). In contrast, virus expression of the
FrAmE virus at 4 weeks was widespread; however, in-
fection was again vascular in nature, with limited expres-
sion in the CNS parenchyma (cf., Fig. 2C). Consistent
with these observations, a histopathological survey of
the brains of these animals failed to reveal evidence of
spongiform neuropathology (Figs. 2B and 2D and Table
1). These results suggest that while CNS virus infection
could be expanded by generation of the FrAmE chimera,
neither virus was capable of efficiently infecting the CNS
parenchyma when animals were inoculated by a periph-
eral route.
Transplantation of NSCs expressing either the 4070A
or the FrAmE virus
The failure of 4070A and FrAmE to cause neurodegen-
eration raises the possibility that amphotropic virus neu-
rovirulence may simply depend upon the efficient spread
of virus to the CNS parenchyma. Therefore, based on our
previous experiments demonstrating that CNS transplan-
tation of virus-expressing NSCs can dramatically en-
hance the ability of a virus to infect parenchymal cells
and cause neurodegeneration, we applied this approach
to analysis of the neurovirulence of the 4070A and FrAmE
viruses.
To accomplish this task we first infected the mouse
NSC cell line C17.2 with either the 4070A or the FrAmE
virus and characterized the infection in culture. As shown
in Figs. 3A–3C, the infected NSCs robustly expressed the
amphotropic Env protein on their cell surface, and this
infection did not alter the expression of the NSC marker,
nestin (Figs. 3D–3F), nor the expression of the genetic
marker protein -galactosidase (not shown). Further-
more, the infected NSCs released virus into the culture
supernatant, yielding titers of 1–2  106 FFU/ml for both
the 4070A and the FrAmE viruses (see Table 1). Impor-
tantly, no MCF viruses were detected in these culture
supernatants (1 FFU/ml).
The uninfected and amphotropic virus-infected NSCs
characterized above were then inoculated into the lateral
and fourth brain ventricles of P0 IRW mice. Over the
4-week time course during which these mice were fol-
lowed, no evidence of clinical neurological signs were
observed for any of the NSC-transplanted animals (Table
1). An immunohistochemical survey of the brains of
these mice for amphotropic envelope protein showed
that the 4070A- and FrAmE-expressing NSC transplants
dramatically increased the level of virus expression
TABLE 1






















— ip 0/0 0/10 1/1 0/10 0/10 0/4
— NSCs 0/0 0/9 1/1 0/9 0/9 0/4
4070A ip 6.0/0 9/9 4/1 0.6/1 0/9 0/9 0/5
4070A NSCs 5.9/0 15/15 5.0 0.5/3.2 0.3 7/15 0/15 0/8
FrAmE ip 6.2/0 19/19 5.1 0.4/2.3 0.7 7/19 0/19 0/8
FrAmE NSCs 6.2/0 23/23 4.9 0.3/2.3 0.3 15/23 0/23 0/11
FrAmE  MCF ip 5.9/6.0 13/13 5.1 0.5/3.8 0.7 13/13 0/13 0/7
FrAmE  MCF NSCs 5.9/6.0 12/12 5.6 0.2/4.1 0.4 12/12 0/12 0/7
a Animals were infected with virus directly by intraperitoneal (ip) injection or indirectly via transplantation of virus-infected C17.2 cells into the lateral
and fourth ventricles (NSCs) of P0 mice.
b Titers given are in focus-forming units per milliliter (FFU/ml) of supernatant derived from confluent cultures of virus-infected cells, either NIH 3T3s
(ip) or C17.2 NSCs. Cell supernatants were also screened for polytropic (MCF) viruses in vitro (see d below) to confirm that the MCFs observed in
vivo arose within the animals, unless specifically infected in vitro.
c Infected and uninfected animals were examined for the appearance of infectious virus in the serum at 4 weeks of age to assess the extent of
exogenous and/or endogenous MuLV expression.
d Viremia titers were determined for the amphotropic viruses using monoclonal antibody 83A25 (Evans et al., 1990) and for MCF viruses using a
mixture of Hy7, 514, and 516 monoclonal antibodies (Chesebro et al., 1983). MCF viremia titer averages were calculated using data from positive
animals only.
e Neuropathology was assessed throughout the brain with specific emphasis on areas known to exhibit vacuolar neurodegenerative changes after
either ip inoculation of FrCasE or transplant of NSCs expressing the CasBrE molecular clone 15-1 (Lynch et al., 1996). These areas included the spinal
cord, cerebral cortex, forebrain, striatum, septum, colliculi, thalamus, pons, medulla, and deep cerebellar nuclei.
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within the CNS parenchyma (cf., Figs. 4A and 4C) com-
pared to that in ip-inoculated mice (Figs. 2A and 2C).
Histopathological analysis of the infected brains for ev-
idence of virus-associated spongiform neurological
changes, however, were consistently negative, as shown
by the representative examples from the deep motor
cortex in Figs. 4B and 4D. The lack of neuropathology in
these mice led us to evaluate animals which were ip
inoculated with the highly neurovirulent ecotropic virus
FrCasE as a positive control. As shown in Figs. 4E and 4F,
FrCasE Env expression (Fig. 4E) was observed at levels
equal to or below those obtained after transplanting
4070A or FrAmE NSCs. Nonetheless, the FrCasE virus
expression induced neuropathological changes (Fig. 4F)
and clinical neurological disease (Portis et al., 1990) by
17 days following virus inoculation. The relative level of
CNS virus expression mediated by the different experi-
mental manipulations was confirmed by p30 Gag immu-
noblotting using protein extracts from the entire brains of
both transplanted and ip-inoculated animals (Fig. 5).
The failure to observe clinical neurological signs and
associated spongiform neuropathology in the face of
robust 4070A virus expression contrasts dramatically
with our current and prior observations with neuroviru-
lent ecotropic retroviruses (Lynch et al., 1991, 1995, 1996,
1999) and the findings of Munk et al. (1997) for the
MoAmphoV virus. To investigate whether these differ-
ences could be due to a failure of 4070A and FrAmE to
infect microglial cells, we examined the brains of NSC-
transplanted mice for colocalization of amphotropic Env
and the microglial marker F4/80 by double-label immu-
nofluorescence microscopy. As shown by the examples
in Fig. 6, significant amphotropic Env expression was
detected in microglial cells in animals transplanted with
either the 4070A- or the FrAmE-expressing NSCs. Fig-
ures 6C and 6D provide an example of how the highly
FIG. 2. Virus distribution and CNS histology following peripheral inoculation of 4070A and FrAmE viruses. (A and C) Indirect immunofluorescence
staining for amphotropic Env protein using monoclonal antibody 83A25 at 4 weeks post-ip inoculation. (A) A representative example of the focal
infection of vascular elements (arrowheads) seen after 4070A infection taken from the cerebral cortex. Such foci occurred sporadically throughout the
brains of 4070A-infected mice. (C) An example of the more widespread vascular CNS infection seen after peripheral infection by FrAmE (also taken
from the cerebral cortex). Despite the significant vascular infection noted for FrAmE (arrowheads), virus spread to cells within the parenchyma was
very limited. (B and D) Representative H&E-stained sections of the cerebral cortex of 4070A- and FrAmE-infected mice, respectively, which show that
the virus infection seen in A and C was not sufficient to induce acute spongiform neuropathology. Bars, 100 m.
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migratory NSCs likely mediate efficient widespread virus
infection of microglial cells through cell-to-cell contact.
Importantly, these results indicate that the amphotropic
Env was capable of mediating infection of microglia
within the brain; however, the expression of the ampho-
tropic viruses within these cells still failed to precipitate
spongiform neuropathology.
The neurovirulence results obtained herein for the
4070A env-containing viruses were consistent with the
original reports of DesGroseillers et al. (1984) and Old-
stone et al. (1983), but differed markedly from those
reported for the MoAmphoV chimeric virus (Munk et al.,
1997). In an attempt to understand these differences we
examined serum samples from the ip-inoculated and
NSC-transplanted mice for the appearance of recombi-
nant polytropic or mink cell focus-forming (MCF) viruses
using specific antibodies in a virus focus assay. As
summarized in Table 1, no circulating MCF viruses were
detected in the serum of uninoculated, 4070A-inoculated,
or control NSC-transplanted mice. However, greater than
50% of the mice infected with the 4070A chimeric virus
FrAmE or transplanted with amphotropic virus-express-
ing NSCs scored positive for MCF viruses in serum.
Importantly, direct immunochemical examination of the
NIH 3T3 producer cells, culture supernatants, or the
infected NSCs failed to show evidence of MCF virus
expression or production in vitro, suggesting that the
MCF viruses observed were arising in vivo.
To evaluate whether the amphotropic/MCF virus mix-
ture arising in infected animals might contribute to neu-
ropathogenesis, a high titer virus mixture was generated
in vitro on 3T3 cells. This virus mixture either was inoc-
ulated into neonatal mice ip or was used to infect C17.2
NSCs, which were then transplanted into P0 mice. The
NIH 3T3 cells and NSCs generated virus mixtures that
titered at 6  105 for 4070A and 6  105 for MCF viruses
(Table 1). Transplanted NSCs were greater than 75%
positive for the amphotropic virus (using 83A25), and
greater than 45% were positive for polytropic virus (using
monoclonal antibodies 514, 516, and Hy7). As summa-
rized in Table 1, both ip-inoculated and NSC-transplanted
amphotropic/polytropic virus-infected animals failed to
show clinical neurological disease through 4 weeks of
observation. Histopathological analysis of the brains of
these animals also showed no evidence of spongiform
neuropathology, indicating that the viruses arising in the
IRW mice were not capable of precipitating acute neu-
ronal degeneration when coexpressed with the ampho-
tropic viruses.
FIG. 3. Expression of amphotropic Env and nestin in C17.2 NSCs infected with 4070A and FrAmE viruses. (A–C) Indirect immunofluorescence
analysis for viral env protein using monoclonal antibody 83A25. Note that uninfected control cells (A) did not stain, while cells infected with either
4070A (B) or FrAmE (C) were readily detectable. (D–F) The amphotropic virus-infected C17.2 cells (E, 4070A; F, FrAmE) continued to express the stem
cell marker nestin, indistinguishable from control cells (D), indicating that their stem cell properties had not been significantly altered as a result of
the infection. NSC coexpression of Env and nestin was confirmed by flow cytometry (not shown), and Table 1 summarizes the virus production from
amphotropic virus-infected NSCs. Bars, 50 m.
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DISCUSSION
In this report we have revisited the issue of whether
the env gene of the 4070A virus harbors neurovirulence
determinants. To investigate this question we first tried
placing the 4070A env in the Friend FB29 virus back-
ground to improve CNS infection efficiency after periph-
eral virus inoculation. However, in contrast to the obser-
vations made for other FB29-based chimeras containing
either ecotropic (Askovic et al., 2000; Lynch et al., 1991;
FIG. 4. Transplantation of amphotropic virus-expressing NSCs leads to significant CNS virus expression in the absence of neuropathologic
changes. Representative examples of amphotropic virus expression within the cerebral cortex after NSC transplant at 28 days posttransplant are
shown (A, 4070A; C, FrAmE), as assessed by indirect immunofluorescent staining for the Env protein. Note that virus expression is abundant within
the CNS parenchyma for both amphotropic virus NSC transplant regimens. Interestingly, Env expression was consistently higher in animals
transplanted with 4070A NSCs than in those transplanted with FrAmE NSCs (see Fig. 5). Transplanted mice were assessed for the appearance of
spongiform neuropathology by H&E staining (B and D); however, no histological changes were observed regardless of whether the NSCs were
expressing 4070A (B) or FrAmE (D). In contrast, animals peripherally inoculated with FrCasE showed both parenchymal infection (E) and abundant
spongiform neuropathology (F). Bars, 100 m.
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Portis et al., 1990) or polytropic envs (Hasenkrug et al.,
1996; Portis et al., 1995; Poulsen et al., 1999; Robertson et
al., 1997), the FrAmE chimera was not able to efficiently
spread to the CNS parenchyma. Nonetheless, we did
observe that the FrAmE chimera significantly increased
the level of vascular infection in the brain compared to
the 4070A wild-type virus, suggesting that the FB29 back-
ground positively affected viral replication kinetics.
Whether this involved neuroinvasiveness determinants
in the 5 untranslated region (5-UTR) of FB29 as identi-
fied by Portis and colleagues (1991) (Fujisawa et al.,
1998) is not known. However, given that the FB29 back-
ground was not sufficient for overcoming the inability of
the 4070A virus to spread to the CNS parenchyma, these
results suggest that MuLV neuroinvasiveness determi-
nants are not limited to the 5 UTR, but also involve
determinants within env. Given our observation that both
4070A and FrAmE spread to endogenous microglia after
virus dissemination by transplanted NSCs, a restriction
at the level of env–receptor interaction within the CNS
parenchyma seems unlikely. Defining where and how
amphotropic env influences neuroinvasiveness will re-
quire further study.
In order to bypass the CNS entry limitation observed
for the amphotropic viruses in our initial experiments, we
delivered the wild-type 4070A and FrAmE viruses directly
into the CNS via transplanted NSCs. Consistent with
previous reports for ecotropic and polytropic viruses
(Lynch et al., 1996, 1999; Poulsen et al., 1999), NSC-
mediated virus dissemination resulted in high-level virus
expression in the brain with significant infection of mi-
croglia, the critical CNS target required for inducing
neurodegeneration. Nonetheless, the NSC-mediated mi-
croglial infection was not sufficient for inducing acute
spongiform neuropathological changes or clinical neuro-
logical disease. This result contrasts with the observa-
tions made for the neurovirulent CasBrE viruses, in
which even minimal focal infection of microglia coin-
cided with neuropathological changes (cf., (Lynch et al.,
1995, 1999). In the current analysis, the level of ampho-
tropic virus expression within regions susceptible to
neuropathological changes was equivalent to or higher
than that attained by the highly neurovirulent ecotropic
virus FrCasE (Figs. 4 and 5). It is possible, however, that
the viral burden necessary for a 4070A env-containing
virus to cause disease may be much greater than that
required for a neurovirulent ecotropic virus. Nonetheless,
given the efficiency by which NSCs appear to deliver
virus to microglia, the simplest interpretation of these
results is that the 4070A env gene, at least in the context
of either the wild-type or the Friend FB29 backgrounds,
does not contain neurovirulence determinants.
So, how can the lack of neurovirulence observed in
this study be reconciled with the observations of Munk
and co-workers (1997), who provided compelling evi-
dence that the 4070A env-containing virus, MoAmphoV,
was neurovirulent? Based on the various differences
between these two studies, we can only speculate as to
what the contributing factors might be. Specifically, there
were differences in the viruses employed, the modes of
virus dissemination, the mouse strains employed, the
disease evaluation periods, and the detection of recom-
binant MCFs. With regard to the viruses employed, the
env gene used in both studies was derived from the
same 4070A amphotropic virus clone (Miller et al., 1985),
and a direct sequence comparison of the env regions
showed no differences within the SU region (not shown).
However, it is possible that single point mutations in env
arising in vivo could dramatically affect the ability of the
amphotropic virus to induce disease, as has been shown
by the studies on the ecotropic Moloney virus ts1 (re-
viewed in Wong and Yuen, 1992). Alternatively, the differ-
ences in pathology and disease could have resulted from
non-env differences in the viral backgrounds. Our find-
ings to date for the ecotropic CasBrE virus indicate that
while retrovirus neurovirulence determinants map to the
env gene, additional viral structural components are re-
quired for disease induction (Lynch et al., 1996, 1999).
With regard to the modes of virus dissemination, the
studies on MoAmphoV required the coinoculation of ei-
ther an ecotropic or an MCF helper virus to accelerate
neuropathogenesis and clearly distinguish neurodegen-
erative disease from leukemia. Thus, the possibility ex-
ists that a second virus or endogenous viral element may
be required for 4070A-induced disease. The likelihood
FIG. 5. Immunoblot assessment of total virus load in the CNS after
peripheral versus NSC-mediated infection by 4070A and FrAmE. Equiv-
alent whole brain extracts, taken from animals at 28 days following
virus exposure, were resolved by 12.5% SDS–PAGE and immunoblotted
with polyclonal rabbit anti-p30gag antiserum after transfer to PVDF
membranes. This antiserum detects the pr65gag precursor protein, its
proteolytic fragments, and the mature p30 Gag protein. Six different
brain samples were analyzed for each amphotropic virus inoculation
regimen, of which two are shown in the figure. For comparison, brain
extracts were evaluated from animals that were either not infected (28
days old) or infected with FrCasE and killed 17 days post-ip infection,
after the appearance of clinical neurological disease. The levels of
virus expression achieved in the CNS via NSC delivery of the ampho-
tropic viruses was consistently greater than that noted for the neuro-
virulent FrCasE virus.
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that such virus–virus interactions would occur in vivo
would be influenced by several factors. These include
the virus background, the mouse strains employed, the
number and tropism of viruses present in the inoculum,
the cell types encountered by the virus prior to entering
the critical target in the CNS, and the length of time
available for virus–virus interactions to occur (i.e., latency
period). To avoid these additional factors, we used NSCs
to deliver a single 4070A env-containing virus directly
within the CNS and evaluated the effects acutely. How-
ever, even with these constraints we routinely observed
the appearance of MCF viruses in response to FrAmE
infection, thus highlighting the complications inherent in
any evaluation of retroviral neuropathogenesis.
In conclusion, the data presented here provide com-
pelling evidence that the 4070A env is not inherently
neuropathogenic. However, given the ability of ampho-
tropic env-containing viruses to interact with endoge-
nous viral sequences and promote the appearance of
circulating MCF viruses, it is possible that unique am-
photropic virus interactions with either exogenous or
endogenous viral elements induce spongiform neurode-
generation. Resolving these outstanding issues for am-
photropic virus neurovirulence will contribute a greater
understanding to how retroviruses in general induce
neurodegeneration and will provide valuable insight ap-
plicable to neurovirulent human retroviruses such as HIV
and HTLV-1.
MATERIALS AND METHODS
DNA constructs, viruses, and cells
The chimeric proviral construct, pFrAmE, containing
the 4070A amphotropic env in the Friend virus clone
FB29 background (Perryman et al., 1991; Sitbon et al.,
1986) (Accession No. Z11128) was generated by ex-
FIG. 6. Transplantation of amphotropic virus-expressing NSCs leads to infection of microglia. Double-label immunofluorescence staining for viral
Env (83A25, green) and microglia (F4/80, red) was carried out in both 4070A NSC- and FrAmE NSC-transplanted animals at 28 dpi to assess
whether the amphotropic viruses could effectively spread from the transplanted NSCs to host microglia. (A and B) A section from the brain stem of
an animal transplanted with 4070A NSCs using a fluorescein filter set (A) and a rhodamine filter set (B). The arrows indicate Env-positive cells (green),
which are clearly identifiable as microglia by virtue of their F4/80 reactivity (red). (C) A merged image of 83A25 (green)- and F4/80 (red)-stained
sections from the cerebral cortex of an animal transplanted with FrAmE NSCs. Note the abundance of orange and yellow staining, indicative of the
colocalization of Env and microglia, demonstrating that significant infection of endogenous host microglia could be accomplished via NSC
transplantation. (D) A higher magnification of a region within (C), which specifically illustrates the ability of a transplanted NSC (large arrowhead,
green) to deliver virus to an endogenous microglial cell through cell-to-cell contact (small arrowhead, yellow). Bars, 50 m.
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changing a SphI to BsmI fragment from a pSP72-based
unpermutted Friend proviral clone, pFB29-57, with the
same region from pAMS (Accession No. AF010170; kindly
provided by A. D. Miller, Fred Hutchinson Cancer Re-
search Center, Seattle, WA). This fragment contains 3
pol and all of the env-encoding region except 106 bp at
the 3 end, which are encoded by sequences within the
FB29 background. The permuted proviral clone p4070A
(Miller and Buttimore, 1986) was used to generate the
wild-type 4070A virus (a gift from L. Evans, Rocky Moun-
tain Laboratories, Fort Collins, Co). The env-encoding
region of pFrAmE was sequenced (Cleveland Genomics)
and shown to be identical to that reported for pAMS in
the GenBank database.
FrAmE, 4070A, and FrCasE virus stocks were gener-
ated by transfecting recombinant proviral plasmid DNAs
into NIH 3T3 fibroblasts. NIH 3T3 fibroblasts, dunni fibro-
blasts, and C17.2 NSCs were grown in Dulbecco’s mod-
ified Eagle medium supplemented with 10% fetal bovine
serum, 10 mM sodium pyruvate, 2 mM glutamine, and
100 units each per milliliter penicillin, streptomycin, and
amphotericin B. Amphotropic/polytropic virus mixtures
were generated by infecting NIH 3T3 cells in the pres-
ence of polybrene (8 g/ml) with pooled serum from four
mice that were infected with the FrAmE virus and were
positive for the presence of both amphotropic and poly-
tropic viruses. Virus titers of both tissue culture super-
natants and serum samples were determined using a
focus assay on dunni cells (Czub et al., 1991). Ampho-
tropic virus was detected using either monoclonal anti-
body 83A25 (Evans et al., 1990) or a polyvalent pig anti-
serum to a Triton X-100 extract of purified amphotropic
MuLV (National Cancer Institute, Bethesda, MD). Poly-
tropic virus was detected using monoclonal antibodies
514, 516, and Hy7 (Chesebro et al., 1983).
C17.2 NSCs (Snyder et al., 1992) were cultured and
infected with 4070A, FrAmE, and the FrAmE/polytropic
virus mixture as previously described (Lynch et al., 1996).
At the time of transplant, infected and uninfected NSCs
were evaluated for expression of amphotropic and poly-
tropic viral Env and nestin (a marker specific for undif-
ferentiated neural stem cells) by indirect immunofluores-
cence microscopy and fluorescence-activated cell sort-
ing (Lynch et al., 1996). Immunostaining for Env was
carried out using monoclonal antibodies 83A25 (to detect
amphotropic viruses) and/or 514, 516, and Hy7 to detect
polytropic viruses after fixation with 10% phosphate-buff-
ered formalin. To detect nestin, cells were additionally
permeabilized with 0.1% Triton X-100 in phosphate-buff-
ered saline (pH 7.3) for 5 min prior to staining with an
anti-rat nestin monoclonal antibody (PharMingen). Pri-
mary antibody labeling was detected using either fluo-
rescein isothiocyanate (FITC)-labeled goat anti-mouse
IgG (for anti-nestin, 514, 516, and Hy7) or FITC-labeled
anti-rat IgG for 83A25 (Cappel). Supernatants from in-
fected and uninfected NSCs were evaluated in a virus
focus assay to assay the productivity of the cellular
infection and to evaluate whether any recombinant poly-
tropic virus might arise in vitro.
Mice, inoculations, and NSC transplantations
All mice used in these experiments were IRW strain
mice, which have been characterized previously to be
highly susceptible to the neurodegenerative effects of
neurovirulent N- and NB-tropic MuLVs. Mice were bred,
housed, and cared for in the specific pathogen-free an-
imal facility at the Northeastern Ohio Universities Col-
lege of Medicine. All animal procedures were carried out
in accordance with American Association for the Accred-
itation of Laboratory Animal Care guidelines and were
approved by the Animal Care and Use Committee at
NEOUCOM.
Animals were infected peripherally by ip injection of
30–50 l of virus stocks within 24 h of birth (P0). Alter-
natively, virus-infected C17.2 NSCs were transplanted
into the fourth and lateral cerebral ventricles of P0 mice
as previously outlined (Lynch et al., 1996). Control and
experimental mice were evaluated daily for clinical neu-
rological signs as previously described (Czub et al., 1994;
Lynch et al., 1991; Portis et al., 1990). Animals were
deeply anesthetized using methoxyflurane and killed by
decapitation at 28–32 days of age, except for FrCasE-
inoculated mice, which were killed at 17 days postinocu-
lation. Serum was obtained and evaluated for the pres-
ence of circulating virus by the focus assay indicated
above. Brains, spinal cords, and spleens were dissected
from the animals and either immersion fixed in 4% para-
formaldehyde/PBS overnight for later histological evalu-
ation or snap frozen over liquid nitrogen for subsequent
immunoblotting and immunolocalization analysis.
CNS immunostaining, immunoblotting, and
histopathology
Amphotropic Env protein expression in the CNS was
examined in four to eight mice per experimental group
and minimally included the medulla, pons, cerebellum,
thalamus, colliculus, hippocampus, cerebral cortex, sep-
tum, and striatum. Env was detected by indirect immu-
nofluorescence on frozen sections using monoclonal an-
tibody 83A25 as described (Lynch et al., 1991). Alterna-
tively, amphotropic virus expression was detected in
frozen and paraffin sections using a pig antiserum made
against a Triton X-100 extract of purified amphotropic
(A)-MuLV virions (National Cancer Institute). The pig an-
tibody was detected directly using FITC-conjugated goat
anti-pig IgG antibody (Research Diagnostics) or indi-
rectly in frozen and paraffin sections using biotin-conju-
gated goat anti-pig IgG (Research Diagnostics) and Su-
persensitive streptavidin–peroxidase reagent (Biogenex)
as described previously (Lynch et al., 1991). Double im-
munofluorescence detection of the microglial marker
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F4/80 and amphotropic Env was carried out as described
(Lynch et al., 1999) using a rabbit polyclonal antibody to
detect F4/80 (a gift from S. Gordon, Oxford University)
and the rat monoclonal antibody 83A25. All fluorescent
images captured were of equivalent duration and gain to
allow direct comparison between samples. Images were
captured using a Spot 2e digital camera (Diagnostic
Instruments) attached to an Olympus Provis microscope.
Immunoblotting for p30 Gag was carried out as previ-
ously described (Lynch and Portis, 1993), except that
total brain extract samples were resolved by 12.5% SDS–
PAGE prior to transfer to PVDF membranes. At least four
different brain samples were evaluated for each experi-
mental group. Equivalent brain samples were loaded in
each lane and were based on the brain weight at the
time of extraction. Representative examples of each ex-
perimental group are shown in Fig. 5.
Histological assessment of neuropathological changes
resulting from virus infection was carried out on brains
which were immersion fixed in 4% paraformaldehyde/PBS
for 4 h at room temperature, sectioned into 3-mm pieces,
and fixed overnight in 4% paraformaldehyde/PBS prior to
dehydration and embedding in paraffin. 10 m coronal
sections were collected on slides, deparaffinized, and
stained with hematoxylin and eosin for histological exami-
nation by brightfield microscopy. In addition, sections adja-
cent to those evaluated for neuropathology were stained for
amphotropic virus expression using pig anti-A-MuLV after
antigen retrieval (Lynch et al., 1999) to assure that the
regions being evaluated were infected. Brain sections
taken from the forebrain through the hindbrain were exam-
ined for all mice in each experimental group. Particular
attention was paid to those brain regions previously re-
ported to become vacuolated in response toMuLV infection
(Czub et al., 1994; Lynch et al., 1996; Munk et al., 1997).
Examples representative of all brain regions surveyed are
shown in Figs. 2 and 4, and the data for all brain regions are
summarized in Table 1.
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